Trying to keep up with the gh stock price today can feel like a full-time job. This article breaks down the latest numbers and what they might mean for Guardant Health. We’ll look at where the stock is right now, how it’s been doing, and some basic info about the company itself. Think of this as a quick check-in to see what’s happening with GH stock.
Key Takeaways
- The gh stock price today is around $107.40 in after-hours trading, down slightly from its closing price.
- Guardant Health’s stock has seen a wide range in the past year, hitting a high of $120.74 and a low of $34.88.
- The company’s market cap is about $13.86 billion with over 128 million shares outstanding.
- Guardant Health is focused on cancer diagnostics using blood and tissue tests, aiming to find cancer early.
- The next earnings release for Guardant Health is scheduled for February 19, 2026, with no current dividend or stock split information available.
Guardant Health Stock Price Today: Real-Time Updates
Alright, let’s take a look at what’s happening with Guardant Health (GH) stock right now. Keeping tabs on the stock price is pretty important if you’re invested or thinking about it. It’s like checking the weather before you head out – you want to know what conditions to expect.
Current GH Stock Price
As of the latest update, the stock is trading around $107.40. That’s a small dip of about 0.17% in after-hours trading. Remember, after-hours trading can be a bit more volatile since fewer people are usually trading. The regular session closed at $107.58, which was a decent jump of 2.43% from the previous day. It’s always a good idea to watch both the regular session close and any after-hours movement.
After-Hours Trading Activity
During the after-hours session, the volume is typically lower. We saw about 57,795 shares change hands after the market closed. This is significantly less than the 1.7 million shares traded during the main trading hours. This lower volume means that even small trades can have a bigger impact on the price during this period.
Daily Price Range and Volume
Looking at the day’s trading, the stock hit a high of $107.67 and a low of $100.26. This gives you a sense of the price swings that happened today. The total volume for the day was substantial, with over 1.7 million shares traded. This level of activity suggests there was a good amount of interest in GH stock today. For more detailed stock information, you can check out Guardant Health, Inc. (GH) stock information.
Guardant Health Financial Performance Metrics
Let’s take a look at some of the numbers behind Guardant Health (GH) to get a better picture of its financial health. It’s not just about the stock price, you know? Understanding these metrics can tell us a lot about how the company is doing.
Market Capitalization and Shares Outstanding
First off, we have the market cap, which is basically the total value of all the company’s stock. As of today, February 11, 2026, Guardant Health’s market capitalization is around $13.86 billion. This is calculated by multiplying the current stock price by the total number of shares available. Speaking of shares, the company has about 128.84 million shares outstanding. This gives us a sense of the company’s size in the market.
Key Profitability Ratios
Profitability is where things can get a bit complex, especially for growth companies like Guardant Health. For the trailing twelve months (TTM), the Earnings Per Share (EPS) is negative $3.21, and the Price-to-Earnings (P/E) ratio is -33.48. This negative EPS means the company isn’t profitable on a per-share basis right now. The forward P/E ratio, looking ahead, is around -42.19. We also see a negative EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of -$402.20 million for the TTM. The Return on Equity (ROE) is also quite negative at -4,584.47%.
However, it’s not all bad news on the profitability front. The Gross Margin for the TTM is a healthy 63.76%. This means that after accounting for the direct costs of producing its tests and services, Guardant Health keeps a good chunk of its revenue. The Net Margin, though, is negative at -44.18%, showing that overall expenses are higher than revenue.
Debt and Equity Analysis
When we look at how the company is financed, we check its debt levels. The Debt-to-Equity ratio, as of the most recent reporting period (MRQ), is -314.44%. A negative ratio here can indicate that the company has more liabilities than equity, which is something to keep an eye on. It suggests the company might be relying more on debt or other forms of financing rather than shareholder equity to fund its operations.
Guardant Health Stock Performance Over Time
Looking at how Guardant Health’s stock has been doing over the past year gives us a good picture of its journey. It’s not always a straight line up, as you know, stock prices can be pretty wild.
52-Week High and Low Performance
Over the last 52 weeks, Guardant Health (GH) stock has seen its ups and downs. The highest it got was $120.74, which happened back on January 22, 2026. On the flip side, the lowest it dipped to was $34.88 on March 10, 2025. This wide range shows the volatility the stock has experienced. It’s important to keep these numbers in mind when thinking about where the stock might go next.
Previous Day’s Closing Price
Yesterday, Guardant Health closed at $105.03. This is a key data point because it sets the stage for today’s trading. The difference between yesterday’s close and today’s current price tells us how the market is reacting to the latest news or general sentiment about the company.
Average Daily Trading Volume
Volume is basically the number of shares traded in a day. For Guardant Health, the average daily trading volume is around 2.24 million shares. This gives us an idea of how much interest there is in the stock. A higher volume often means more people are buying and selling, which can lead to bigger price swings. It’s a sign of how active the stock is in the market.
Understanding Guardant Health’s Business
Company Overview and Mission
Guardant Health is a company that’s all about using science to help people live longer, cancer-free lives. They focus on precision oncology, which basically means tailoring cancer care to the individual. They do this by developing advanced tests, mostly using blood and tissue samples, to get a better picture of what’s going on with a disease. Think of it like getting super detailed information that helps doctors figure out the best way to treat cancer, whether it’s catching it super early, keeping an eye on it after treatment, or picking the right medicine.
Their main goal is to "guard wellness" and give people more time. It’s a pretty big mission, aiming to make a real difference in how cancer is handled.
Key Leadership Team
Running a company like Guardant Health takes a solid team. Here are a few of the folks in charge:
- Helmy Eltoukhy Ph.D.: He’s the Chairperson of the Board and also serves as a Co-Chief Executive Officer. He’s clearly a big part of the company’s direction.
- Michael Bell: He’s the Chief Financial Officer, so he’s the one keeping a close eye on the money side of things.
- Darya Chudova: As the Chief Technology Officer, she’s likely involved in developing and managing the tech behind their tests and data analysis.
- Kumud Kalia: He’s the Chief Information Officer, probably focused on how the company handles its data and IT systems.
Corporate Headquarters Location
If you ever wanted to send them a letter or just know where they’re based, Guardant Health’s main office is located at:
3100 Hanover Street
Palo Alto, CA 94304
United States
Upcoming Guardant Health Events
Keeping an eye on Guardant Health’s schedule is pretty important if you’re invested in the company. It’s not just about the stock price moving day-to-day; you also want to know when big announcements might be coming.
Scheduled Earnings Release Dates
Companies like Guardant Health have specific dates when they report their financial results. These earnings reports can really move the stock price, so mark your calendar.
- The next earnings release is expected on February 19, 2026.
- This is when they’ll share how they performed financially over the last quarter.
- Investors will be looking closely at revenue, profit, and any forward-looking statements.
Dividend and Stock Split Information
Guardant Health doesn’t currently pay dividends, and there haven’t been any stock splits announced recently. It’s good to know this, though, as dividends can be a source of income for shareholders, and stock splits can change the number of shares outstanding and the price per share.
- Dividend: None currently.
- Dividend Yield: Not applicable.
- Stock Split: No recent activity.
It’s always a good idea to check the latest investor relations news for any updates on these fronts. Sometimes companies participate in investor conferences, which can also offer insights. For instance, Guardant Health is scheduled to be at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026, and the Leerink Partners Global Health Conference on March 10, 2026. These events are great opportunities to hear directly from the company’s leadership about their strategy and outlook. You can find more details about these investor events.
Guardant Health Stock Price Today: Technical Indicators
When looking at Guardant Health’s stock, it’s helpful to check out a few technical indicators. These aren’t crystal balls, but they can give us a sense of how the stock is behaving in the market.
Beta Value and Market Volatility
First up, let’s talk about Beta. For Guardant Health (GH), the Beta value is around 1.66. What does that mean? Basically, it suggests that GH stock tends to be more volatile than the overall market. If the market goes up by 1%, GH might move by more than 1%, and if the market drops, GH could potentially drop more too. This higher Beta means investors should be prepared for bigger price swings. It’s a measure of how sensitive the stock is to broader market movements.
Forward Price-to-Earnings Ratio
Another metric to consider is the Forward Price-to-Earnings (P/E) ratio. For Guardant Health, the forward P/E is approximately -42.19. A negative P/E ratio usually indicates that a company is not currently profitable. In GH’s case, this suggests that analysts expect the company to continue facing losses in the near future, but they also anticipate future earnings growth. It’s a bit of a mixed signal, showing that while profitability isn’t there yet, there’s an expectation of improvement down the line. This is something to keep an eye on as the company grows and works towards profitability.
Wrapping Up Our Look at Guardant Health Stock
So, that’s the latest on Guardant Health’s stock. We’ve seen how the numbers have been moving today, with the stock trading around $107.40 after the market closed. It’s been a bit of a mixed bag, closing up yesterday but showing a small dip in after-hours trading. Keep in mind, this is all based on the data we have right now, and stock prices can change quickly. Guardant Health is doing important work in cancer detection, but like any company, its stock performance is influenced by a lot of factors. It’s always a good idea to check back for updates and do your own research before making any decisions.
Frequently Asked Questions
What is the current price of Guardant Health stock?
The stock price for Guardant Health (GH) is currently around $107.40. This is the price after the market closes, and it has seen a small dip of about 0.17%.
How has Guardant Health’s stock performed this year?
Over the past 52 weeks, the stock has traded between a low of $34.88 and a high of $120.74. This shows a pretty wide range of ups and downs for the stock.
What does Guardant Health do?
Guardant Health is a company that uses special blood and tissue tests, along with smart computer programs, to help find and understand cancer. Their goal is to help people live longer, healthier lives by catching cancer early and guiding treatment.
How big is Guardant Health as a company?
The company is valued at about $13.86 billion, and there are roughly 128.84 million shares of its stock available. This gives you an idea of its size in the market.
When will Guardant Health announce its next earnings report?
Guardant Health is expected to release its next earnings report on February 19, 2026. This is when they share how well they’ve been doing financially.
Is Guardant Health’s stock considered risky?
The ‘Beta’ value for Guardant Health is 1.66. A Beta over 1 means the stock tends to be more jumpy than the overall stock market, suggesting it might be a bit riskier but also could have higher potential for big moves.
